PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
http://ww2.peerview.com
Kenneth Gordon, MD - Potential Clinical Implications of the Latest Data on Approved and Emerging Therapies for Psoriasis: A Recap From Washington, DC
Go online to PeerView.com/YDK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dermatology discusses select abstracts focused on psoriasis that were presented at the 2019 American Academy of Dermatology (AAD) Annual Meeting, held from March 1-5, in Washington, DC. An overview and practical insights are offered on new data that speak to a rapidly evolving treatment landscape in psoriasis. Upon completion of this activity, participants should be better able to: Apply new data on the efficacy, safety, and optimal clinical use of approved therapies when managing patients with psoriasis, Assess the potential clinical utility of late-breaking data on the efficacy, safety, and tolerability of emerging therapeutic options for the treatment of psoriasis, Identify the potential impact of emerging therapies on the future management of psoriasis, particularly in patients with difficult-to-treat disease.